Eupraxia Pharmaceuticals logo

Eupraxia Pharmaceuticals

EPRX | NASDAQ
Chart Builder DCF Calculator
$7.34
-$0.81 (-9.94%)
At close: Nov 16, 2026, 4:00 PM ET
$7.34
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-9.94%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
25.2
-1.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #924/1021 (Top 90%)

Key Statistics

Market Data

Market Cap $493.56M
1D Range
7.32 8.26
52W Range
5.81 9.10

Valuation (TTM)

PE -7.13
PB 4.09
EV/EBITDA -6.26

Valuation (NTM)

Forward PE N/A
Forward PEG -0.13
Price Target $17.00
Loading financial charts...

Profile

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technolo...

Sector Healthcare
Industry Biotechnology
Employees 49
IPO Date Apr 5, 2024
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$17.00
Upside
+131.61%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.